General information, not medical advice or an insurance coverage decision. MedraxDME operates as an out of network supplier. Coverage, supplier enrollment requirements and patient responsibility depend on the plan and an individual review.
Step 1: discuss the prescribed system
Talk with the clinician managing your diabetes about whether a CGM is appropriate and which exact system to prescribe. Standard Dexcom G7 and Dexcom G7 15 Day are separate sensor options with different age and use instructions. Do not choose a model solely because it appears on an insurance search result or seems to have a longer wear period.
If the discussion is about moving to G7 15 Day, Dexcom says a new prescription is required. The prescriber should make the clinical decision and send the appropriate order. Dexcom: A new prescription for G7 15 Day. Use the current United States Dexcom instructions for the exact product.
At the appointment, ask who will provide training and how follow up will work. If a caregiver helps with your equipment, involve that person with your permission. A clear training plan belongs alongside the prescription, rather than being left until the first supplies arrive.
Step 2: identify medical or pharmacy benefits
A Dexcom prescription can be processed through different channels depending on the insurance arrangement. Dexcom explains that some members have pharmacy coverage while others receive supplies through an insurance designated distributor. Dexcom: Pharmacy and distributor access. Do not assume that a prescription sent to one channel can be paid under the other without review.
Call the number on your current insurance card and ask which benefit applies to the exact prescribed model. If the representative transfers you to a pharmacy benefits manager or medical equipment team, keep the case reference and the name of the department. Ask whether that department can confirm the designated dispensing organization.
A useful question is: “For my current plan, where should my clinician send this exact prescription, and what approval steps must happen first?” That is more precise than asking whether the insurer covers Dexcom in general. Record the answer for your own use and share it with the clinician through the office's appropriate channel.
Step 3: confirm that the supplier can serve the plan
Check the supplier arrangement before the prescription and records move between offices. Ask your plan whether the specific organization can provide the device under your benefit, whether out of network benefits exist, and whether any separate authorization is needed. The insurer's brand name does not establish the network for every plan it administers.
Original Medicare also advises confirming that the clinician and DME supplier are enrolled and asking about assignment. Medicare: Continuous glucose monitor coverage. A website that explains Medicare rules does not, by itself, establish the website owner's enrollment or your claim's eligibility.
MedraxDME describes its services as out of network and reviews requests individually. Nationwide support means people across the United States can contact the team; it does not guarantee participation with every insurer. If your plan requires a different supplier or pharmacy, ask the plan for the correct contact so the request can proceed through the appropriate route.
Step 4: arrange the required records securely
The exact paperwork depends on the benefit and current policy. For Medicare CGM, the treating practitioner's records need to establish the coverage criteria and required visits. CMS has separate rules for the written order and the supporting medical record. A prescription alone does not necessarily provide every fact needed for a claim. CMS: Glucose Monitors coverage policy L33822 and CMS: Standard Documentation Requirements A55426.
Ask the receiving organization for a specific list of missing items. Then ask which clinical office should send them and through what secure method. This prevents repeated requests for an entire chart when only a particular dated note or corrected order is needed. Never edit a clinician's records or add a diagnosis to make paperwork appear complete.
MedraxDME's website starts with a callback. Do not put member numbers, diagnoses, glucose readings, insurance card images or prescriptions into that form or an ordinary public message. The team should explain the appropriate next step for any further information after contact is established.
Step 5: clarify what has actually been approved
There are several stages between an inquiry and a supply arrangement. Contact details may be received. A prescription may be on file. Benefits may have been checked. An authorization may be requested. The final dispensing and claim decisions may still be outstanding. Ask which stage applies rather than relying on a broad statement that the request is “in progress.”
Before agreeing to proceed, request an explanation of the prescribed item, supply period, authorization status and any patient responsibility. Ask who will contact you if a requirement is not met. Keep the written information or reference number so you can compare it with later notices.
Insurance coverage does not necessarily pay every part of an equipment request. An individual review should explain the financial and administrative details relevant to your plan. If an answer is unclear, pause and ask for clarification before accepting a supply arrangement, particularly when moving between medical and pharmacy benefits.
Step 6: check equipment and training arrangements
Confirm the sensor generation, compatible receiver or phone arrangement and any connected insulin pump configuration. Under the Medicare DME benefit, the qualifying durable receiver or pump display rules must be met even when a smartphone is also used. CMS: Glucose Monitor policy article A52464.
Before opening a shipment, compare the exact product name with the prescription and the arrangement you confirmed. If something does not match, contact the dispensing organization before using it. A mistaken shipment should not become an unplanned change in treatment. Keep the paperwork that identifies the supplied item and the support contacts.
Arrange training with the clinical team or appropriate device support resource. Discuss what to do when readings are unavailable, which instructions to follow for alerts and whom to contact for clinical concerns. The supplier's administrative review is not a substitute for learning how to use the prescribed system safely.
Step 7: make a refill and support plan
Ask how to request ongoing supplies, when to contact the dispensing organization and what information it needs about remaining supplies. A routine refill is different from a manufacturer replacement for a product problem. Keep those two support routes in your contact list so an early sensor failure does not become a confusing new insurance order.
For Medicare, the required follow up visit every six months remains part of continuing CGM coverage. CMS: Glucose Monitors coverage policy L33822. Schedule clinical follow up and respond to requests for refill confirmation. If insurance changes, tell the relevant organization before the next supply review instead of assuming the previous arrangement continues.
For your personal notes, use a simple status list: prescribed model, responsible clinician, benefit route, dispensing organization, records outstanding, authorization status, training contact and next action. This is a preparation tool, not a form to send through the public website. You can begin a MedraxDME discussion through the callback form without including health or insurance identifiers.
Questions and answers
Can I start without an insurance card upload?
Yes. The MedraxDME website collects basic contact details for a callback. It does not collect insurance cards, member IDs or prescriptions in the public form.
Does submitting the form place an equipment order?
No. It requests contact. Product suitability, documentation, benefits and fulfillment arrangements must be reviewed before supplies are arranged.
Should I cancel my current supplier immediately?
Do not cancel a working supply arrangement simply because a new inquiry was submitted. Confirm the new route and timing first, and discuss any clinical supply gap with your care team.
Sources and updates
- Dexcom: A new prescription for G7 15 Day
- Dexcom: Pharmacy and distributor access
- Medicare: Continuous glucose monitor coverage
- CMS: Glucose Monitors coverage policy L33822
- CMS: Glucose Monitor policy article A52464
- CMS: Standard Documentation Requirements A55426
- Dexcom: Current United States user guides
Read our editorial and correction policy. For current plan rules, check the applicable official policy and contact your plan. Tell us about a correction.